Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Mobile Version
A-  |   A  |   A+
Werbung
 
Suchergebnis - Abbildungen und Graphiken
 
Alle Journale wurden nach systolic blood pressure durchsucht Treffer 1 - 22 von 22

Medizinische Publikationen (31)  ::   Abbildungen und Graphiken  ::   Volltext (2874)

Neue Suche:         Erweiterte Suche    Hilfe zur Suche

in allen Journalen nach  Bildtitel    Bildkeywords   Bildsummary   Autoren      Mindestens ein Wort  Alle Wörter   
1. Lautsch D; Saely CH; Traindl O; Eber B; Pfeiffer K; Drexel H
Is there a Link Between Non-HDL Cholesterol and Blood Pressure? An Age and Gender Directed Analysis of 7500 Hypertensive Outpatients
Non-HDL Cholesterol - Blood Pressure
Journal für Kardiologie - Austrian Journal of Cardiology 2012; 19 (1-2): 11-16
(A): Non-HDL Cholesterol; (B): Sitting Systolic; (C): Sitting Diastolic Blood Pressure in Men and Women, Distribution over the age groups. Values are means, bars represent two-sided 95% CIs.

Keywords: AGEAlterBlutdruckDiagrammflowchartFrauKardiologiemanMannnon-HDL cholesterolNon-HDL-Cholesterinwoman
2. Gasser S; Zunko S; Kraigher-Krainer E; Gasser R
White-Coat Hypertension and Socio-Interactive Dynamics: A Case Report
Blood Pressure
Journal of Clinical and Basic Cardiology 2011; 14 (1-4): 23-24
(a) Systolic blood pressure in mmHg; (b) Diastolic blood pressure in mmHg; Sample: BP assessment by different persons: measurement by patient (1), daughter (2), mother (3), pharmacist (4), GP (5), and professor of internal medicine (6). One can see the reproducible socio-emotional dynamics of both systolic and diastolic blood pressures in this patient. Number of measurements for each sample: 5.

Keywords: blood pressure
3. Zweiker R; Perl S; Sock S; Stoschitzky K; Plank J; Kvas E
Carvedilol and Hydrochlorothiazide in Hypertensives with Metabolic Disorder: Not Always Bad News - An Austrian Survey
Blood pressure
Journal für Hypertonie - Austrian Journal of Hypertension 2009; 13 (2): 22-26
Systolic and diastolic blood pressure (mmHg) reduction; baseline visit (VO) to visit after 1 year (V4).

Keywords: blood pressureBlutdruckHypertonie
4. Eber B; Weber T; Artmann A; Enayati S
Fixkombination Enalapril/Nitrendipin in der täglichen Praxis - Effektivität und Verträglichkeit bei 1.262 österreichischen Hypertonikern
Systolischer Blutdruck
Journal für Hypertonie - Austrian Journal of Hypertension 2007; 11 (2): 22-25
Systolischer Blutdruck (Angaben in Mittelwerten und Standardabweichung)

Keywords: Hypertoniesystolic blood pressuresystolischer Blutdruck
5. de la Sierra A
Effects of Eprosartan on Pulse Pressure
Eprosartan - blood pressure
Journal of Clinical and Basic Cardiology 2005; 8 (1-4): 11-14
Journal of Clinical and Basic Cardiology 2006; 9 (Sonderheft 1): 9-12
Effects of eprosartan on different blood pressure components in patients with isolated systolic hypertension (ISH) or systodiastolic hypertension (SDH). In patients with ISH the effect on systolic (SBP) and pulse pressure (PP) is maintained, whereas the effect on diastolic (DBP) and mean (MBP) pressures is clearly less pronounced.

Keywords: blood pressureBlutdruckdiagramDiagrammhypertensionHypertonie
6. Dia-Präsentation von Merck Gesellschaft mbH.
Micardis(R) - MicardisPlus(R) - Hypertonie (38 Abbildungen)

Keywords: BehandlungBlutdruckHypertonieMerck GmbHMicardisMicardis PlusPharmakologieTelmisartanTherapie
7. Dia-Präsentation von SERVIER
EUROPA-Studie (Perindopril) (60 Abbildungen)

Keywords: CoversumEUROPA-StudiePerindoprilServier Austria GmbH
8. Wascher TC
Diabetes Mellitus - How to Prevent Macrovascular Disease?
UKPDS - Complications - Blood Pressure
Journal für Kardiologie - Austrian Journal of Cardiology 2003; 10 (4): 149-151
Rate of microvascular complications and myocardial infarction in the UKPDS according to the mean updated systolic blood pressure over the entire study duration (corrected for age, gender and ethnicity). Modified from [6]

Keywords: CardiologyGrafikgraphKardiologieMicrovascular Complicationsmikrovaskuläre Komplikationenmyocardial infarctionMyokardinfarktsystolic blood pressuresystolischer BlutdruckUKPDS-StudieUKPDS-Studie
9. Hansson L
The Impact of Systolic Blood Pressure Control in Angiotensin II Antagonist Blockade
Eprosartan - Enalapril - Blutdruck
Journal of Clinical and Basic Cardiology 2001; 4 (2): 131-134
Effect of eprosartan and enalapril on blood pressure in 21 African-American patients and 263 non-African-American patients with hypertension. Redrawn after Hedner T, 1999 [23].

Keywords: blood pressureBlutdruckDiagrammEnalaprilEnalaprilEprosartanEprosartan
10. Hansson L
The Impact of Systolic Blood Pressure Control in Angiotensin II Antagonist Blockade
Eprosartan - Enalapril - Blutdruck
Journal of Clinical and Basic Cardiology 2001; 4 (2): 131-134
Effect of eprosartan and enalapril on blood pressure in 118 patients with severe hypertension. Redrawn after Hedner T, 1999 [23].

Keywords: blood pressureBlutdruckDiagrammEnalaprilEnalaprilEprosartanEprosartan
11. Hansson L
The Impact of Systolic Blood Pressure Control in Angiotensin II Antagonist Blockade
Sphygmomanometer
Journal of Clinical and Basic Cardiology 2001; 4 (2): 131-134
A sphygmomanometer of the kind used by Riva-Rocci in 1896

Keywords: blood pressureBlutdruckMessungSphygmomanometerSphygmomanometer
12. Malendowicz SL; Chen T; Ennezat PF; Evans T; Jorde UP; LeJemtel TH; Murray L; Sonnenblick EH
The 1166A/C polymorphism of the angiotensin II type 1 receptor gene does not correlate with the blood pressure response to angiotensin II in patients with CHF
Angiotensin II - Dosierung
Journal of Clinical and Basic Cardiology 2001; 4 (1): 75-77
Effective dose of Angiotensin II (AII) (ng/kg) (Pd 20) required to produce increase in Radial Artery Systolic Pressure (RASP) by 20 mmg/Hg was similar in patients with AA and AC/CC polymorphism of AT1 receptor gene. Graph represents the AII Pd 20 in patients with AA and AC/CC polymorphism of AT1 receptor gene 11.35 +/- 1.18 vs 13.21 +/- 2.2 respectively (p = 0.42).

Keywords: Angiotensin IIAngiotensin IIArteria radialisArteria radialisblood pressureBlutdruckDiagrammdosageDosierungSystoleSystole
13. Chrustalev OA; Galimskaja LJ; Gerasimov VG; Konopljanik NV; Moshejko ME; Patrunova OS; Rjabichin EA
Talinolol in patients with stable angina pectoris and concomitant hypertension
Talinolol - Hypertonie
Journal of Clinical and Basic Cardiology 2000; 3 (2): 129-132
Change in mean systolic and diastolic blood pressure and in heart rate during treatment (*p < 0.05 vs baseline value)

Keywords: DiagrammhypertensionHypertonietalinololtalinolol
14. Metzler B; Bilgeri R; Pachinger O
Fulminant course of hypertension caused by phaeochromocytoma
Phäochromozytom - Blutdruck
Journal of Clinical and Basic Cardiology 2000; 3 (1): 67-68
Thirteen-hour systolic and diastolic blood pressure monitoring graph of an antihypertensive treated patient with an unknown Phaeochromocytoma. The x axis indicates the time after admission to hospital (h); the y-axis the blood pressure in mmHg.

Keywords: blood pressureBlutdruckDiagrammhypertensionHypertoniephaeochromocytomaPhäochromozytom
15. Wicher C; Biewald G-A
Left-ventricular dysfunction, heart vagus influences and angiotensin II effects after doxorubicin perfusion in isolated rat hearts
Doxorubicin - Angiotensin-II-Modulation
Journal of Clinical and Basic Cardiology 1999; 2 (2): 259-266
Time courses of heart rate (HR, A), SαT time (B), systolic pressure PS (C) and time constant of contraction τC (D) and changes in above parameters during vagus stimulation (right N. vagus, 10 Hz, 10 V), recorded in an isolated rat heart (modified Langendorff preparation) before and during doxorubicin (DXR) perfusion (20 micromol/L) and after addition of angiotensin II (AII, 1 micro mol/L). AII was added 20 min after DXR application to Tyrode solution. Small vertical arrows which originate from the curves, show changes in the parameters mentioned above, caused by vagus stimulation. Note, that vagus effects were progressively reduced during DXR perfusion. Addition of AII caused positive chronotropic and inotropic effects for a short time. Additionally, AII addition reduced vagus stimulation effects regarding above parameters (especially HR and PS). At the end of experiment, all vagus effects were nearly completely disappeared.

Keywords: Angiotensin IIAngiotensin IIDiagrammdoxorubicindoxorubicinheart rateHerzfrequenzNervus vagusNervus vagussystolic blood pressuresystolischer Blutdruck
16. Szili-Török T; Gingl Z; Halmai L; Kardos A; Rudas L
Windowed FFT - a time-variant spectral analysis: applicability during the head-up tilt test
Kipptisch
Journal of Clinical and Basic Cardiology 1999; 2 (2): 241-244
Typical tilt-induced responses of a tilt-positive patient. Panel A. The RR interval tachogram. The tilting, indicated by a vertical line is reflected by an immediate HR acceleration. The sudden-onset bradycardia after 800 s of the recording coincides with the syncopal episode. Panel B. The systolic BP trend curve reveals transient stabilisation post-tilting, followed by a marked hypotension, eventually leading syncope. Panels C and D. Variations in HR (C) and systolic BP (D) with time, as assessed by windowed FFT in the same arrangement as in Figure 1. The upright tilt manoeuvre is paralleled by elevations in the LFHRV and TFHRV powers. The duration of the elevations in these frequency ranges is prolonged, however, relative to the normal, and they are interrupted by further peakings. The subsequent decreases in the spectral components precede the syncopal episode.

Keywords: blood pressureBlutdruckDiagrammKipptischtilt table
17. Szili-Török T; Gingl Z; Halmai L; Kardos A; Rudas L
Windowed FFT - a time-variant spectral analysis: applicability during the head-up tilt test
Kipptisch
Journal of Clinical and Basic Cardiology 1999; 2 (2): 241-244
Upright tilt-induced responses of a patient from the tilt-negative group. Panel A. Normal heart rate response to upright tilt. The postural change at 600 s of the recording is accompanied by a certain RR interval shortening. Panel B. Although the fluctuations in systolic BP are augmented following the upright tilt, no clinically significant hypotension is recorded. Panels C and D. Variations in HR (C) and systolic BP (D) powers with time, as assessed by the windowed FFT method. Solid lines indicate total power, dashed lines indicate LF power, and dotted lines indicate HF power. The upright tilt manoeuvre elicits transient elevations in the LFHRV and TFHRV power. The BP power reveal immediate tilt-related increases in the same spectral bands, followed by subsequent fluctuations of lesser magnitude. The terminal increases in the BPV components are related to the motion artefacts at the time of termination of tilting.

Keywords: blood pressureBlutdruckDiagrammheart rateHerzfrequenzKipptischtilt table
18. Salvadori A; Arreghini M; Bolla G; Fanari P; Giacomotti E; Longhini E; Miserocchi G; Palmulli P
Cardiovascular and adrenergic response to exercise in obese subjects
Herzfrequenz - Systolischer Blutdruck - Adipositas
Journal of Clinical and Basic Cardiology 1999; 2 (2): 229-236
Heart rate systolic pressure product (HRP) plotted vs. mechanical power output in control and obese subjects. B. Ratio of heart rate systolic pressure product to oxygen consumption (HRP/V·O2) plotted vs. mechanical power.

Keywords: AdipositasBelastungDiagrammexerciseheart rateHerzfrequenzLeistungobesitysystolic blood pressuresystolischer Blutdruck
19. Gasser R; Klein W; Köppel H
Lercanidipine, a new third generation Ca-antagonist in the treatment of hypertension
Lercanidipin - systolischer und diastolischer Blutdruck
Journal of Clinical and Basic Cardiology 1999; 2 (2): 169-174
Mean supine systolic and diastolic blood pressure and heart rate at baseline and after 30, 60 and 90 days treatment with lercanidipine 20-40 mg once (n = 16; diamonds) or twice daily (n = 20; squares) (redrawn according to [46])

Keywords: Diagrammdiastolic blood pressurediastolischer BlutdruckLercanidipinlercanidipinesystolic blood pressuresystolischer Blutdruck
20. Gasser R; Klein W; Köppel H
Lercanidipine, a new third generation Ca-antagonist in the treatment of hypertension
Lercandipin - systolischer Blutdruck
Journal of Clinical and Basic Cardiology 1999; 2 (2): 169-174
Mean decrease in systolic blood pressure (SBP) after 4 weeks of treatment as seen by Circo in 132 patients (redrawn according to [37]; grey: 24 +/- 2 hours post-dose; black: 4-5 hours post-dose)

Keywords: blood pressureDiagrammLercanidipinlercanidipinesystolischer Blutdruck
21. Di Napoli P; Barsotti A; Contegiacomo G; Di Crecchio A; Di Muzio M; Maggi A; Taccardi AA; Tiloca P
Ischaemic preconditioning of rat myocardium: effects on postischaemic coronary endothelium hyperpermeability and microcirculatory damage
Preconditioning - koronare Mikrozirkulation
Journal of Clinical and Basic Cardiology 1998; 1 (1): 37-42
Haemodynamic parameters (systolic aortic pressure, heart rate, cardiac output). SAP: systolic aortic pressure. Data are expressed as mean +/- SD.

Keywords: cardiac outputcardiac outputDiagrammheart rateHerzfrequenzischaemic preconditioningischämisches PreconditioningmicrocirculationMikrozirkulationsystolic blood pressuresystolischer Blutdruck
22. Berger R; Frey B; Hülsmann M; Koller-Strametz J; Pacher R; Sima I; Stanek B
Delayed effects of one-year treatment with low-dose as compared with high-dose enalapril on morbidity and mortality of patients with severe heart failure
Enalapril bei schwerer Herzinsuffizienz - Blutdruck, Plasmakreatinin
Journal of Clinical and Basic Cardiology 1998; 1 (1): 19-24
Mean changes +/- SEM in systolic and diastolic blood pressure and in plasma creatinine from baseline to months 15, 18, 24, 30 and 36 in the low-dose extension group (open bars, n = 41) and in the high-dose extension group (black bars, n = 39). Mean changes +/- SEM in plasma creatinine from baseline to months 15, 18, 24, 30 and 36 in the low-dose extension group (open bars, n = 38) and in the high-dose extension group (black bars, n = 34).

Keywords: blood pressureBlutdruckDiagrammEnalaprilEnalaprilplasma creatininePlasmakreatininSchwere Herzinsuffizienzsevere heart failureStudiestudy
 

 Seite 1 von 1 
 
copyright © 2003–2016 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung